Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: Feb 10, 2026
Date Accepted: Sep 8, 2026

The final, peer-reviewed published version of this preprint can be found here:

Temporal Patterns of Multimorbidity Progression Among Inpatients With a Recorded Hypertension Diagnosis Across Three Counties in Rural Henan, China: Retrospective Cohort Study Using Temporal Network Analysis

Feng R, Mao Y, Wang X, Liu R, Cui M, Liu R

Temporal Patterns of Multimorbidity Progression Among Inpatients With a Recorded Hypertension Diagnosis Across Three Counties in Rural Henan, China: Retrospective Cohort Study Using Temporal Network Analysis

JMIR Public Health Surveill 2026;12:e93217

DOI: 10.2196/93217

PMID: 42912827

Temporal Patterns of Multimorbidity Progression Among Inpatients With a Recorded Hypertension Diagnosis Across Three Counties in Rural Henan, China: A Temporal Network Analysis

  • Ruihua Feng; 
  • Yanna Mao; 
  • Xi Wang; 
  • Rongmei Liu; 
  • Manman Cui; 
  • Rongmei Liu

ABSTRACT

Background:

Hypertension is a key driver of multimorbidity, yet its role in shaping dynamic disease progression, especially in rural populations, remains underexplored.

Objective:

This study aims to apply temporal network analysis to examine hypertension-driven multimorbidity trajectories across three socioeconomically diverse counties in Henan Province, China. Specifically, we sought to investigate how disease patterns evolve over time and identify heterogeneity in progression pathways by sex, age, payment method, and geographic region, to inform precision public health strategies.

Methods:

We analyzed EHR data from 34,099 hypertensive inpatients across three rural counties in Henan, China (2019-2023), constructing a temporal comorbidity network (TCN) of 250 diseases and 1,512 disease transitions. Statistical validation was performed using bootstrap resampling, case-dropping, and permutation tests. Subgroup analyses were conducted by sex, age, insurance type, and region.

Results:

The TCN revealed a “malignant triangle” of hypertension → atherosclerotic heart disease → cerebral infarction. Type 2 diabetes served as a bridging node between macrovascular and microvascular diseases. Sex-stratified analysis showed that women transitioned from hypertension to coronary disease before cerebrovascular events, while men progressed more directly to stroke and diabetes complications. Age-stratified analysis identified complex multi-system progression in patients aged >70. Rural patients under urban–rural resident insurance exhibited more diffuse and complex disease patterns compared to those with urban employee insurance.

Conclusions:

This study demonstrates that hypertension-driven multimorbidity follows a dynamic, heterogeneous trajectory influenced by sex, age, insurance, and region. Temporal network analysis offers a robust framework for identifying critical disease transitions, informing tailored public health strategies.


 Citation

Please cite as:

Feng R, Mao Y, Wang X, Liu R, Cui M, Liu R

Temporal Patterns of Multimorbidity Progression Among Inpatients With a Recorded Hypertension Diagnosis Across Three Counties in Rural Henan, China: Retrospective Cohort Study Using Temporal Network Analysis

JMIR Public Health Surveill 2026;12:e93217

DOI: 10.2196/93217

PMID: 42912827

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.